US Broker Ratings

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a 67% Upside Potential

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector, specifically within the medical devices industry, presents a compelling opportunity for investors with a notable potential upside of 67.09%...

UFP Technologies (UFPT) Stock Analysis: Exploring a 50% Upside Potential in Medical Device Market

UFP Technologies, Inc. (UFPT), a notable player in the medical devices industry, has positioned itself as a formidable force in the healthcare sector with its innovative solutions for medical devices..

Kestra Medical Technologies (KMTS): Investor Outlook Reveals a Promising 66.77% Upside Potential

Investors searching for opportunities in the healthcare sector may find Kestra Medical Technologies, Ltd. (KMTS) an appealing candidate. This Kirkland, Washington-based company is carving out a niche in the medical..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Unveiling a 10.25% Potential Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With its headquarters in Burlington, Massachusetts, LeMaitre Vascular..

Harmony Biosciences Holdings, Inc. (HRMY): Investor Outlook with a 38.82% Upside Potential

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) has garnered significant attention in the healthcare sector, particularly within the biotechnology industry. With a current market capitalization of $2.09 billion, this U.S.-based company..

Opko Health, Inc. (OPK) Stock Analysis: Exploring the 158.93% Upside Potential for Investors

Opko Health, Inc. (NASDAQ: OPK), a dynamic player in the healthcare sector, offers promising opportunities for investors looking for potential growth in the diagnostics and pharmaceuticals industries. Headquartered in Miami,..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Biotechnology Innovator with 106% Potential Upside

Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company headquartered in Singapore, is gaining traction among investors due to its innovative RNA medicines platform, PRISM, and the significant potential..

Indivior PLC (INDV) Stock Analysis: Exploring a 16.71% Upside Potential with Strong Buy Ratings

Indivior PLC (NASDAQ: INDV), a key player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, has captured investor attention with its recent stock performance and..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Exploring a Potential 99.61% Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) stands out in the healthcare sector, particularly within the drug manufacturers’ niche focused on specialty and generic medications. With a market capitalization of $1.76 billion,..

agilon health, inc. (AGL) Stock Analysis: Evaluating the 41% Potential Upside Amid Market Challenges

As an intriguing player in the healthcare sector, agilon health, inc. (NYSE: AGL) has caught the attention of investors with its innovative approach to senior healthcare services. Despite facing some..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Navigating Growth with a 4.84% Upside Potential

GoodRx Holdings, Inc. (NASDAQ: GDRX), a prominent player in the health information services industry, offers a unique platform enabling consumers to compare and save on prescription drug purchases across the..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a Potential 108% Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) is currently a focal point within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $732.45 million, this U.S.-based..

Certara, Inc. (CERT) Stock Analysis: Unveiling a 26% Potential Upside in Healthcare Technology

Certara, Inc. (NASDAQ: CERT) stands at the intersection of healthcare and technology, offering a compelling investment opportunity with a potential upside of over 26%, as suggested by current analyst ratings...

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: High Revenue Growth and Analyst Confidence Signal Potential Upside

Investors looking at ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) may find themselves intrigued by the impressive revenue growth and the bullish sentiment from analysts that hint at a potential upside in..

Addus HomeCare Corporation (ADUS) Stock Analysis: A 21% Upside Potential in the Booming Healthcare Sector

Addus HomeCare Corporation (NASDAQ: ADUS), a prominent player in the healthcare sector, has captured investor attention with its robust outlook and significant growth potential. Specializing in personal care services for..

Evotec SE (EVO) Stock Analysis: A 56% Upside Potential Amidst Strategic Collaborations

Evotec SE (EVO), a prominent player in the healthcare sector, operates as a drug discovery and development company with a significant presence in the United States, Germany, France, the United..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Eyeing a 37% Upside in the Biotech Arena

PTC Therapeutics, Inc. (NASDAQ: PTCT) stands at the forefront of the biotechnology industry with its innovative focus on rare disorders. The company’s current market capitalization is $3.96 billion, reflecting its..

Belite Bio, Inc (BLTE) Stock Analysis: Biotechnology Innovator with 44.34% Upside Potential

Belite Bio, Inc (BLTE) is a promising player in the healthcare sector, specifically within the biotechnology industry. Based in San Diego, California, this clinical-stage biopharmaceutical company focuses on developing novel..

Harrow, Inc. (HROW) Stock Analysis: 56.84% Upside Potential in the Thriving Eyecare Pharmaceutical Market

For investors with an eye on the healthcare sector, Harrow, Inc. (NASDAQ: HROW) presents an intriguing opportunity. As a key player in the eyecare pharmaceutical industry, Harrow has carved out..

Innoviva, Inc. (INVA) Stock Analysis: Unraveling a 97% Potential Upside in Healthcare Innovation

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, is capturing investors’ attention with its robust portfolio of pharmaceutical products and a significant potential upside of 97.31%. Headquartered..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds